v3.26.1
Basis of Presentation - Summary of Subsidiaries which are Wholly Owned and Subject to Control (Details)
12 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Apr. 30, 2024
ImmunoPrecise Antibodies (Canada) Ltd. d/ba/ MindWalk Biologics      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary ImmunoPrecise Antibodies (Canada) Ltd. d/ba/ MindWalk Biologics    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation Canada    
Functional Currency Canadian dollar    
ImmunoPrecise Antibodies (USA) Ltd. ("IPA USA")      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary ImmunoPrecise Antibodies (USA) Ltd. ("IPA USA")    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation USA    
Functional Currency U.S. dollar    
ImmunoPrecise Antibodies (N.D.) LTD      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary ImmunoPrecise Antibodies (N.D.) LTD    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation USA    
Functional Currency U.S. dollar    
ImmunoPrecise Antibodies (MA) LLC      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary ImmunoPrecise Antibodies (MA) LLC    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation USA    
Functional Currency U.S. dollar    
Talem Therapeutics LLC ("Talem")      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary Talem Therapeutics LLC ("Talem")    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation USA    
Functional Currency U.S. dollar    
ImmunoPrecise Netherlands B.V.      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary ImmunoPrecise Netherlands B.V.    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation Netherlands    
Functional Currency Euro    
ImmunoPrecise Antibodies (Europe) B.V. ("IPA Europe")      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary ImmunoPrecise Antibodies (Europe) B.V. ("IPA Europe")    
Equity Interest percentage 0.00% 100.00% 100.00%
Country of Incorporation Netherlands    
Functional Currency Euro    
BioStrand B.V. d/b/a MindWalk      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary BioStrand B.V. d/b/a MindWalk    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation Belgium    
Functional Currency Euro    
Idea Family BV      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary Idea Family BV    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation Belgium    
Functional Currency Euro    
BioKey BV      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary BioKey BV    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation Belgium    
Functional Currency Euro    
BioClue BV      
Disclosure Of Significant Investments In Subsidiaries [Line Items]      
Name of Subsidiary BioClue BV    
Equity Interest percentage 100.00% 100.00% 100.00%
Country of Incorporation Belgium    
Functional Currency Euro